Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatment.

Abstract excerpt

AIM: To investigate the association of hepatitis B virus (HBV) genotype and HBeAg seroconversion after nucleotide analogue treatment. METHODS: Chronic hepatitis B patients receiving lamivudine followed up for at least 6 months post-treatment were studied. Consecutive treatment-naïve patients who were prospectively followed up in the clinic for at least 18 months were studied as controls. HBeAg seroconversion was...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Alanine Transaminase
• Share to Antiviral Agents